Hematologic Oncology Update
Un pódcast de Research To Practice
561 Episodo
-
Biosimilars 2019 | Interview with Hope S Rugo, MD
Publicado: 15/4/2019 -
Biosimilars 2019 | Interview with Gary H Lyman, MD, MPH
Publicado: 15/4/2019 -
Biosimilars 2019 | Interview with Sanjiv S Agarwala, MD
Publicado: 15/4/2019 -
Oncology Today with Dr Neil Love: DLBCL 2019
Publicado: 15/4/2019 -
HL Update 1 2019 | Interview with David J Straus, MD
Publicado: 25/1/2019 -
HL Update 1 2019 | Interview with Radhakrishnan Ramchandren, MD
Publicado: 25/1/2019 -
FL Update 1 2019 | Interview with Nathan H Fowler, MD
Publicado: 25/1/2019 -
FL Update 1 2019 | Interview with Gilles A Salles, MD, PhD
Publicado: 25/1/2019 -
CLL Update 1 2018 | Interview with Prof John G Gribben, MD, DSc, FMedSci
Publicado: 13/12/2018 -
CLL Update 1 2018 | Interview with Jennifer R Brown, MD, PhD
Publicado: 13/12/2018 -
Acute Leukemias Update 1 2018 | Interview with Daniel Pollyea, MD, MS
Publicado: 26/11/2018 -
Acute Leukemias Update 1 2018 | Interview with Jorge E Cortes, MD
Publicado: 26/11/2018 -
MTP HL 2018 | Meet The Professors: A Case-Based Discussion on the Management of Hodgkin Lymphoma
Publicado: 4/10/2018 -
Lymphoma CLL Update 1 2018 | Interview with Laurie H Sehn, MD, MPH
Publicado: 30/4/2018 -
Lymphoma CLL Update 1 2018 | Interview with Andrew D Zelenetz, MD, PhD
Publicado: 30/4/2018 -
Lymphoma Misclassification 2018 | Interview with Fernando Cabanillas, MD
Publicado: 15/2/2018 -
Lymphoma Misclassification 2018 | Interview with Randy David Gascoyne, MD
Publicado: 15/2/2018 -
Lymphoma Misclassification 2018 | Interview with Mitchell R Smith, MD, PhD
Publicado: 15/2/2018 -
Multiple Myeloma Update 1 2018 | Interview with Edward A Stadtmauer, MD
Publicado: 12/1/2018 -
Multiple Myeloma Update 1 2018 | Interview with Sarah A Holstein, MD, PhD
Publicado: 12/1/2018
Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
